Indian markets are experiencing a cheerful mood. Nifty has broken out of its consolidation phase, indicating potential for new highs. Bank Nifty is already in uncharted territory. Analysts suggest a ‘buy on dip’ strategy. IndusInd Bank and Dr Reddy’s are highlighted as stock recommendations with good risk-reward potential. Investors can look forward to further market gains.
Corona Remedies and Wakefit Innovations to list tomorrow; GMP suggests sharp upside for pharma play
Corona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expectations backed by robust subscriptions and